Kienesberger, B.; Obermüller, B.; Singer, G.; Mittl, B.; Grabherr, R.; Mayrhofer, S.; Heinl, S.; Stadlbauer, V.; Horvath, A.; Miekisch, W.;
et al. (S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds. Int. J. Mol. Sci. 2021, 22, 6424.
https://doi.org/10.3390/ijms22126424
AMA Style
Kienesberger B, Obermüller B, Singer G, Mittl B, Grabherr R, Mayrhofer S, Heinl S, Stadlbauer V, Horvath A, Miekisch W,
et al. (S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds. International Journal of Molecular Sciences. 2021; 22(12):6424.
https://doi.org/10.3390/ijms22126424
Chicago/Turabian Style
Kienesberger, Bernhard, Beate Obermüller, Georg Singer, Barbara Mittl, Reingard Grabherr, Sigrid Mayrhofer, Stefan Heinl, Vanessa Stadlbauer, Angela Horvath, Wolfram Miekisch,
and et al. 2021. "(S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds" International Journal of Molecular Sciences 22, no. 12: 6424.
https://doi.org/10.3390/ijms22126424
APA Style
Kienesberger, B., Obermüller, B., Singer, G., Mittl, B., Grabherr, R., Mayrhofer, S., Heinl, S., Stadlbauer, V., Horvath, A., Miekisch, W., Fuchs, P., Klymiuk, I., Till, H., & Castellani, C.
(2021). (S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds. International Journal of Molecular Sciences, 22(12), 6424.
https://doi.org/10.3390/ijms22126424